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Abstract 
Ornithine decarboxylase (ODC) is the first and usually rate-limiting enzyme in the polyamine biosynthetic 
pathway. In a normal physiological state, ODC is tightly regulated. However, during neoplastic transformation, 
ODC expression becomes upregulated. The studies described here show that the ODC mRNA transcript is 
destabilized by the RNA-binding protein tristetraprolin (TTP). We show that TTP is able to bind to the ODC mRNA 
transcript in both non-transformed RIE-1 cells and transformed Ras12V cells. Moreover, using mouse embryonic 
fibroblast cell lines that are devoid of a functional TTP protein, we demonstrate that in the absence of TTP both 
ODC mRNA stability and ODC enzyme activity increase when compared to wild-type cells. Finally, we show that 
the ODC 3′ untranslated region contains cis acting destabilizing elements that are affected by, but not solely 
dependent on, TTP expression. Together, these data support the hypothesis that TTP plays a role in the post-
transcriptional regulation of the ODC mRNA transcript. 
Introduction 
Ornithine decarboxylase (ODC) is the first biosynthetic enzyme in the polyamine pathway and converts the 
amino acid ornithine to the diamine putrescine, which is subsequently converted to the higher polyamines 
spermidine and spermine, respectively (Nowotarski et al. 2015; Pegg 2006). Under normal physiological 
conditions, ODC intracellular levels are tightly regulated through transcriptional and translational control and 
protein degradation (Bello-Fernandez et al. 1993; Shantz and Pegg 1999; Wallon et al. 1995; Zhao and 
Butler 2001). However, it has been well documented that an increased activity of ODC correlates with a variety 
of malignancies, including breast, colon, and skin cancers (Gerner and Meyskens 2004; Nowotarski et 
al. 2013, 2015). Particularly in the skin, the link between elevated ODC enzyme activity and tumor formation is 
indisputable, thereby making ODC an attractive chemoprevention target for combating non-melanoma skin 
cancer (Feith et al. 2005; Nowotarski et al. 2015; O’Brien 1976; Smith et al. 1997). 
Changes in the intracellular polyamine pools have been shown to affect the localization of RNA-binding proteins 
(RBPs), which can influence the stability and translational efficiency of their target mRNA transcripts (Rao and 
Wang 2010). These mechanisms provide a rapid means of regulating gene expression. RBPs have been classically 
shown to bind to the 3′ untranslated region (UTR) of labile transcripts (Parker and Sheth 2007). Three categories 
of RBPs have been defined: those that stabilize mRNA, those that destabilize mRNA, and those that can both 
stabilize and destabilize mRNA (Guhaniyogi and Brewer 2001). Moreover, the physiological relevance of mRNA 
stability has been highlighted as an underlying factor in a variety of disease states (Benjamin and Moroni 2007; 
Lopez de Silanes et al. 2007). One such trans-acting RBP is tristetraprolin (TTP). 
TTP is one of the three widely distributed RBPs that contain Cys–Cys–Cys–His-zinc (CCCH-zinc) finger RNA-
binding domains. Other family members of TTP include butyrate response factor 1 (BRF1) and BRF2. These RBPs 
classically bind to UUAUUUUAUUU sequences in the 3’UTR of the target message (Brewer et al. 2004). TTP binds 
to, and destabilizes, numerous transcripts, including TNF-α, GM-CSF, VEGF, and IL-3 (Carballo et al. 2000; Lai et 
al. 1999; Stoecklin et al. 2000; Suswam et al. 2008; Taylor et al. 1996a). Moreover, TTP interacts with proteins 
that are associated with RNA decay, such as DCP1, DCP2, XRN1, and CCR4, and has been shown to stimulate 
mRNA deadenylation and promote mRNA decay (Brooks and Blackshear 2013; Fenger-Gron et al. 2005). Similar 
to the stabilizing RBP HuR, TTP has been found to shuttle rapidly from the nucleus to the cytoplasm in response 
to serum and phorbol esters (Taylor et al. 1996b). In response to cellular stress, TTP has been shown to localize 
to stress granules and P-bodies, and it is hypothesized that this functions to relocate stalled mRNA to the mRNA 
decay machinery (Kedersha et al. 2005; Stoecklin et al. 2004). 
Studies show that TTP expression is lower in tumor samples when compared to non-tumorigenic tissue samples 
(Brennan et al. 2009). In an array study using a variety of epithelial cancer cDNA samples, as well as non-
transformed controls, TTP mRNA levels were shown to be decreased in 65 % of tumors when compared to non-
transformed controls. The reduction in TTP mRNA was frequent in thyroid, breast, lung, ovary, and uterine 
tumors. Western blot analysis confirmed that TTP protein expression was also suppressed in tumor samples 
(Brennan et al. 2009). These data suggest that TTP expression is frequently repressed in epithelial tumors and 
correlates TTP expression with the tumor development. 
Previously, we demonstrated that ODC is regulated at the level of RNA stability in both keratinocyte-derived 
cells and rat intestinal epithelial (RIE-1) cells in part by binding to HuR, which stabilizes ODC mRNA in cells that 
have undergone neoplastic transformation (Nowotarski and Shantz 2010; Origanti et al. 2012). The work 
described here shows that TTP also binds to the ODC transcript in parental RIE-1 cells, and in cells that are 
transformed by H-Ras12V expression. Using cells from TTP knockout mice, we demonstrate that the absence of 
TTP correlates with increased ODC enzyme activity as well as a stabilization of ODC mRNA. Further studies 
suggest that the ODC 3' UTR also contains both TTP-dependent and TTP-independent negative regulatory 
elements. Moreover, we show using an in vivo model of non-melanoma skin cancer progression that TTP 
expression is reduced as tumor grade progresses. Thus, these studies add to our understanding of ODC post-
transcriptional regulation by RBPs, and highlight TTP as a trans-acting element that influences ODC post-
transcriptional regulation. 
Materials and methods 
Cell culture 
RIE-1 cells (a generous gift from Dr. Kenneth Brown, The Barbraham Institute, Cambridge, UK) were maintained 
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10 % fetal bovine serum (FBS) and 1 % 
penicillin/streptomycin. Ras12V cells were generated from RIE-1 cells as described previously (Origanti and 
Shantz 2007). For transfections, either pcDNA3-FLAG-TTP (a generous gift of Dr. Jens Lykke-Anderson, University 
of Colorado) or empty vector control (Life Technologies, Carlsbad, CA) was transiently transfected into Ras12V 
cells using Lipofectamine 2000 (Life Technologies), and cells were harvested 48 h later. TTP+/+ and TTP−/− mouse 
embryonic fibroblasts (MEFs, a generous gift from Dr. Perry J. Blackshear, NIEHS, Durham, NC) derived from 
E14.5 mouse embryos were cultured in DMEM supplemented with 10 % FBS and 1 % penicillin/streptomycin. 
These cells have been described previously (Lai et al. 2006). All cell culture stock flasks were incubated at 37 °C 
in a humidified atmosphere of 95 % air, 5 % CO2. 
Animal treatment 
All experiments involving mice were carried out in compliance with the Guide for the Care and Use of Laboratory 
Animals, and protocols approved by the Animal Care and Use Committee of the Pennsylvania State University 
College of Medicine. For mouse experiments, the dorsal surface of FVB/N mice (6–8 weeks) was treated with a 
single application of DMBA followed by multiple applications of TPA (25 weeks, 2X/week) to induce tumors, as 
described previously (Carr et al. 2012). Animals were euthanized, and dorsal skin was treated with a depilatory 
agent for 3 min, washed, and tumors were removed. Tumor samples were placed into ice-cold 1X RIPA buffer 
(20 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1 % NP-40, 1 % sodium deoxycholate, 
2.5 mM sodium pyrophosphate, 1 mM-beta-glycerophosphate, 1 mM Na3VO4, 1 μg/ml leupeptin, 1 mM PMSF, 
and 1X protease inhibitor cocktail) (Santa Cruz Biotechnology, Santa Cruz, CA). Following sonication, samples 
were centrifuged, and the supernatants were collected. Samples were flash-frozen and later processed in RIPA 
buffer by homogenizing for 30 s on ice using a Polytron homogenizer, tissue was centrifuged at 30,000×g for 
30 min at 4 °C, and supernatants were collected. Equal amounts of protein were then subjected to SDS-PAGE. 
Western blot analysis 
Western blotting was conducted as described previously (Origanti and Shantz 2007). Membranes were probed 
using antibodies that recognized TTP (EMD Millipore/Merck KGaA, Germany), HuR, or GAPDH (Santa Cruz 
Biotechnology). These antibodies were used at a 1:1000 dilution. A polyclonal antibody to ODC was prepared as 
described previously (Shantz 2004). Western blots were quantitated using the Syngene software (Syngene, 
Frederick, MD). 
Assay for ODC enzyme activity 
ODC enzyme activity was determined by a radiometric assay, measuring the amount of 14CO2 released from each 
reaction in which L-[1-14C] ornithine is enzymatically converted to 14CO2 by ornithine decarboxylase. Collection 
and analysis were carried out, as described previously (Coleman and Pegg 1998). 
RNA stability using Actinomycin D assay and qRT-PCR 
Cells were grown to 70 % confluency and treated with 10-μg/ml Actinomycin D (Sigma-Aldrich, St. Louis, MO). 
RNA was harvested using the TRIzol reagent according to the manufacturer’s instructions (Invitrogen) at 0, 4, 
and 8 h post-Actinomycin D treatment. Total RNA was then used in reverse transcription and PCR amplification. 
qRT-PCR was performed using the Step One Plus Real-Time PCR system (Applied Biosystems), and the following 
primers: ODC sense, 5′-CGAGAACCATGAGCAGCTTTAC-3′; ODC antisense, 5′-GCATCCTTATCGTCAGAGGAAG-3′ 
(annealing at 58 °C); Cyclophilin A sense, 5′-GCAGGTCCATCTACGGAGAG-3′; and Cyclophilin A antisense, 5′-
CTGGGAACCGTTGTGTTTGG-3′ (annealing at 58 °C). To quantify relative gene expression, the comparative cycle 
threshold (C t) method was utilized, and the C t values for the gene of interest were normalized to the C t values 
of Cyclophilin A, and were presented in relation to the untreated (0 h time point) controls. Analysis was 
performed on the Step One Plus Real-Time PCR software (Applied Biosystems). 
Biotin-labeled RNA protein-binding assays 
A synthetic ODC transcript was generated by isolating total RNA from Ras12V cells and then using reverse 
transcriptase to produce cDNA. The cDNA was used as a template for PCR amplification of the full-length ODC 
3′UTR. The sense primers for each reaction contained the T7 RNA polymerase promoter sequence on the 5′ end 
(T7): 5′-CCAAGCTTCTAATACGACTCACTATAGGGAGA-3′ to allow further amplification. The PCR templates were 
used to transcribe biotinylated RNAs using the T7 polymerase and biotin-labeled CTP (Invitrogen) as reported 
previously (Zou et al. 2006). The resulting biotin-labeled transcripts (15 μl) were incubated with 120 μg of 
cytoplasmic lysate for 30 min at room temperature. The RNA–protein complexes were then harvested using 
paramagnetic streptavidin-conjugated Dynabeads (Invitrogen), and were analyzed by Western blot analysis 
using the TTP antibody described above or an HuR antibody (Santa Cruz Biotechnology). 
RNP (ribonucleoprotein) immunoprecipitation 
For immunoprecipitation (IP) of endogenous RNA–protein-binding complexes, 2000 μg of cytoplasmic lysate was 
incubated for 1 h at room temperature with a 100-μl suspension of protein-A SureBeads (BioRad, Hercules, CA) 
that had been precoated with 15 μg of either rabbit IgG (Cell Signaling, Danvers, MA) or TTP antibody (Millipore) 
as described (Nowotarski et al. 2011). The RNA IP material was analyzed by washing the beads with PBS-Tween 
buffer (0.05 % Tween-20) and further incubated with 0.05-mg/ml proteinase K, 10 % SDS, and 100-μl PBS-Tween 
for 30 min at 55 °C. RNA was precipitated using phenol–chloroform extraction in the presence of glycoblue 
(Invitrogen). RNA from the IP was then reverse transcribed using Superscript VILO (Invitrogen) to detect the 
presence of ODC mRNA. qRT-PCR was performed using the Step One Plus Real-Time PCR system (Applied 
Biosystems), and the following primers: ODC sense, 5′-CGAGAACCATGAGCAGCTTTAC-3′; ODC antisense, 5′-
CTACACATTGATCCTAGCAGAA-3′ (annealing at 58 °C); GAPDH sense, 5′-CCAGCCTCGTCCCGTAGACAAAA-3′; and 
GAPDH antisense, 5′-TCGGCCTTGACTGTGCCGTTGAA-3′. To quantify relative gene expression, the comparative 
cycle threshold (C t) method was utilized, and the C t values for the gene of interest were normalized to 
the C t values of GAPDH, and were presented in relation to the rabbit IgG controls. Analysis was performed on 
the Step One Plus Real-Time PCR software (Applied Biosystems). 
Luciferase assays 
The ODC 3′UTR was cloned into the pGL3-Control vector (Promega, Madison, WI), and placed downstream of 
the Firefly luciferase reporter gene. This plasmid is denoted as pODC3′UTRLuc. To investigate the influence of 
the ODC 3′UTR on luciferase activity, TTP+/+ and TTP−/− cells were transfected with either 2 μg of pODC3′UTRLuc 
or the pGL3 Control using Lipofectamine 2000 transfection reagent as per the manufacturer’s instructions (Life 
Technologies). Mock-transfected cells were treated with Lipofectamine 2000 only. The pRL-SV40 Renilla reporter 
plasmid was co-transfected at 0.2 μg per plate to act as a transfection efficiency control (Promega). Fourty-eight 
h after post-transfection, cells were harvested in 1X Passive Lysis Buffer (Promega) and assayed using the Dual-
Luciferase Kit as per the manufacturer’s instructions (Promega). For each sample, the Firefly luciferase activity 
was normalized to the Renilla luciferase activity, and the data are expressed as the Firefly/Renilla ratio. The data 
were normalized to the pGL3 Control. 
Statistics 
The results are expressed as the means ± standard errors (SE). Statistical analysis was performed using 
Student’s t-test. P values of <0.05 were considered significant. 
Results 
TTP is elevated in non-transformed cells and is able to bind to a synthetic ODC 3′UTR in both non-transformed 
and transformed cells 
Previous work in our lab has shown that ODC is post-transcriptionally regulated by the RBP HuR. We 
demonstrated that the ODC 3′UTR contains numerous AU-rich elements, which are thought to be target sites for 
not only HuR but also other RBPs (Nowotarski and Shantz 2010). Furthermore, we showed that HuR is capable of 
binding to deletion mutants of the ODC 3′UTR that are significantly less stable than the wild-type 3′UTR (Origanti 
et al. 2012). These results suggest that other RBPs may be competing with HuR for binding to a given target 
within the ODC transcript. One of the most common HuR-binding competitors is TTP (Blaxall et al. 2000; 
Gardiner et al. 2015; Ming et al. 2001). Therefore, a biotinylated pulldown assay was conducted in both non-
transformed RIE-1 cells and Ras12V transformed cells to determine whether TTP could bind to synthetic 
transcripts corresponding to the full-length ODC 3′UTR. The data show that TTP binds to the ODC 3′UTR in both 
RIE-1 cells and Ras12V cells (Fig. 1a). Interestingly, TTP actually associates slightly more strongly with the ODC 
transcript in the transformed Ras12V cells (Fig. 1a). However, when the same cell extract was analyzed for HuR 
association with the ODC 3′UTR, there was a massive increase in HuR association to the ODC 3′UTR in Ras12V 
cells (Fig. 1a). In fact, the ratio of HuR bound to TTP bound increased more than ten-fold in Ras12V cells 
compared to RIE-1 cells. Analysis of whole cell lysates revealed that TTP protein levels are higher in RIE-1 cells 
than in Ras12V cells (Fig. 1b), and our previous results showed that HuR protein levels were higher in Ras12V 
cells when compared to RIE-1 cells (Origanti et al. 2012). To determine the effect of increasing TTP in Ras12V 
cells, we overexpressed a FLAG-TTP plasmid. The results show that cells overexpressing TTP contained 40 % less 
ODC protein compared to cells transfected with an empty vector control (Fig. 1c), consistent with destabilization 
of the ODC transcript by TTP. 
 
Fig. 1. TTP is able to bind to synthetic ODC 3′UTR transcripts in both non-transformed RIE-1 cells and 
transformed Ras12V cells. a Cytoplasmic lysates (120 µg) prepared from RIE-1 or Ras12V cell lines were 
incubated with 15 µl of synthetic biotin-labeled ODC 3′UTR transcript for 30 min at room temperature. The 
resulting ribonucleoprotein complexes were pulled down using streptavidin beads, and the presence of TTP and 
HuR was assessed via Western blot analysis. This experiment was done in duplicate with similar results. b Whole 
cell lysates were prepared in 1X RIPA buffer. TTP was detected via Western blot analysis. This experiment was 
conducted in duplicate with similar results. c Flag-TTP plasmid or empty vector was transiently transfected into 
Ras12V cells, and TTP, ODC, and GAPDH were analyzed by Western blot analysis. This experiment was 
conducted in duplicate with similar results 
 
TTP binds to endogenous ODC mRNA in wild-type MEFs 
To more fully understand the results in RIE-1 cells, we used MEFs derived from TTP knockout mice. The TTP 
protein in these cells is not truly knocked out, but rather is truncated and, therefore, non-functional (Taylor et 
al. 1996a). The intracellular association of ODC mRNA and TTP was assessed via an RNA immunoprecipitation 
(RNA IP) assay that allows measurement of the endogenous association of TTP and its target mRNAs. Previous 
studies have shown that TTP association with target RNA can range from 12.5-fold to 60-fold enrichment in wild-
type MEFs; although in these studies, cells were treated with budesonide to induce TTP (Ishmael et al. 2008). 
Our results show an association of TTP with ODC mRNA in wild-type MEF cytoplasmic lysates, and quantitation 
using qRT-PCR analysis revealed a 3.9-fold increase in ODC mRNA in TTP pulldown material when compared to 
the IgG control (Fig. 2). 
 
Fig. 2 TTP associates with endogenous ODC mRNA in wild-type MEF cells. Cytoplasmic lysates from wild-type 
MEFs were used for IP with anti-TTP or nonspecific rabbit IgG. RNA in the IP material was extracted using phenol 
chloroform extraction, used to make cDNA, and analyzed for the presence of ODC transcript using primers that 
were specific for the ODC coding region. The data were analyzed via qRT-PCR. The values are the mean ± SE 
from three separate experiments. P = 0.127 
 
ODC mRNA stability and activity are increased in TTP knockout MEFs when compared to 
wild-type MEFs 
We next wanted to determine the effect of knocking out TTP on ODC mRNA stability. In agreement with the RNA 
IP experiment discussed above, ODC stability increased four-fold in TTP knockout MEFs when compared to wild-
type MEFs (Fig. 3a). Interestingly, TTP wild-type MEFs displayed a two-fold higher level of steady-state ODC 
mRNA compared to TTP knockout MEFs (data not shown). These data suggest that ODC is post-transcriptionally 
regulated in these cells at the level of translational efficiency or transcript degradation. To determine whether a 
reduction in ODC mRNA stability correlated with a decrease in ODC enzyme activity, we assessed the ODC 
enzyme activity in both wild-type and TTP knockout MEFs. A statistically significant reduction (two-fold) in ODC 
enzyme activity was observed in log-phase wild-type cells when compared to TTP knockout cells (Fig. 3b). 
 
Fig. 3 ODC mRNA stability and ODC enzyme activity are increased in TTP knockout MEFs when compared to wild-
type MEFs. a TTP wild-type (+/+) and TTP knockout cells (−/−) were used. ODC mRNA half-life was determined 
using 10 µg of Actinomycin D/ml. Total RNA was isolated at the indicated times, and the levels of ODC mRNA 
and GAPDH mRNA were assessed via qRT-PCR, as described in the “Materials and methods”. The results are 
shown as the mean ± SE from three separate experiments. b TTP wild-type (+/+) and TTP knockout (−/−) cells 
were harvested in ODC harvest buffer. An ODC enzyme activity assay was conducted as described in the 
“Materials and methods” section. This experiment was conducted five times (n = 17). A student’s t-test was 
conducted on the data. *P < 0.05 was considered statistically significant when comparing TTP (+/+) cells ODC 
enzyme activity to TTP (−/−) cells ODC enzyme activity. P = 0.0170 
 
To investigate the regulation of ODC by its 3′UTR, we used transient transfections of luciferase reporters. 
Expression of a luciferase reporter vector containing the ODC3′UTR was lower in TTP wild-type cells compared to 
TTP knockouts, suggesting that TTP does play a role in mediating the luciferase expression (Fig. 4). When these 
cells were each compared to their respective empty vector controls, insertion of the ODC 3′UTR into the pGL3 
vector (pODC3′UTRLuc) resulted in a 75 % reduction in luciferase activity in TTP wild-type cells and a 50 % 
reduction in luciferase activity in TTP knockout cells, suggesting the presence of a negative regulatory element in 
the 3′UTR that is not solely dependent on TTP expression (Fig. 4). 
 
Fig. 4 ODC 3′UTR causes a decrease in luciferase reporter activity in MEF cells. TTP wild-type (+/+) and TTP 
knockout (−/−) cells were transfected with either pGL3 control or pODC3′UTRLuc as described in the “Materials 
and methods” section. Fourty-eight h after transfection, cells were assayed for luciferase activity. Firefly 
luciferase activity was normalized to Renilla activity for each sample. The luciferase activity for the pGL3 control 
was set to 100 %. Cells transfected with pODC3′UTRLuc are shown as a percent of pGL3 control activity. Values 
are mean ± SE (n = 7) 
 
TTP protein levels decrease during non-melanoma skin cancer progression 
We used an in vivo mouse model of NMSC to determine the levels of TTP during tumor progression. When we 
examined skin tumors harvested from mice treated with DMBA/TPA for 25 weeks, we saw that as tumor grade 
increases from benign papilloma to squamous cell carcinoma, the level of TTP protein decreases modestly 
(Fig. 5). We did not see consistent levels of our GAPDH loading control across samples in these experiments; 
perhaps, due to the heterogeneity of the tumor tissue being analyzed. The utilization of other loading controls 
did not alter the relative ratios of TTP protein normalized to a loading control (data not shown), suggesting that 
the changes in TTP observed are real. The data shown agree with results published previously suggesting that 
TTP decreases during tumor progression (Brennan et al. 2009). Since ODC protein is known to be induced in skin 
tumors (Gilmour 2007; Gilmour et al. 1985), an increase in ODC mRNA stability brought about by changes in TTP 
binding may play a role in this process. 
 
Fig. 5 TTP expression is reduced as tumor grade increases during NMSC progression. FVB/N mice were treated 
with DMBA and TPA (25 weeks, 2X/week), as described in the “Materials and methods” section. Tissue samples 
were run for the presence of TTP using Western blot analysis. Blots were stripped and probed for GAPDH. 
Western blots were quantified using the SynGene software. Papilloma denotes benign papillomas and 
carcinoma denotes squamous cell carcinomas. The representative blot shows two or three samples from 
different mice 
Discussion 
Our studies show that cytoplasmic TTP binds to a synthetic ODC 3′UTR in both non-transformed RIE-1 cells as 
well as transformed Ras12V cells (Fig. 1a). Moreover, we show that TTP is able to bind to endogenous ODC 
message in these cells (Fig. 2). A functional correlation between TTP and ODC mRNA stability and ODC enzyme 
activity was shown using TTP knockout MEFs (Fig. 3a, b), and the ablation of a functional TTP protein results in 
both a dramatic elevation in ODC mRNA stability, (Fig. 3a) as well as a significant increase in ODC enzyme activity 
(Fig. 3b). Experiments analyzing the influence of the ODC 3′UTR on luciferase activity in our TTP wild-type and 
TTP knockout cell lines revealed that the ODC 3′UTR contains a negative regulatory element that is influenced, 
but not solely dependent on TTP expression, as the insertion of the 3′UTR into the pGL3 control vector showed a 
dramatic decrease in the level of luciferase activity in both TTP wild-type and TTP knockout MEFs (Fig. 4). These 
data are in agreement with previous results shown by Lee et al., in which the 3′UTR of VEGF was fused to the 
luciferase gene in the pGL3 plasmid. When TTP was overexpressed in Colo320 cells, the luciferase activity was 
markedly reduced in comparison to the control pGL3 plasmid, suggesting that TTP is a negative regulator of UTR-
mediated luciferase activity (Lee et al. 2009). Taken together, these data suggest that the RBP TTP is not only 
able to bind to the ODC 3′UTR, but also that the binding of TTP to the ODC 3′UTR destabilizes the ODC mRNA 
message and reduces the overall expression of the ODC protein as measured by ODC enzyme activity assays. 
TTP, a CCH-zinc finger RBP, has been shown to bind to and decrease the mRNA stability of numerous transcripts 
(Brooks and Blackshear 2013). Furthermore, in a study looking at TTP expression in colon cancer, it was found 
that TTP levels were dramatically decreased in adenocarcinoma samples when compared to non-tumorigenic 
controls. The level of TTP had an inverse relationship with a marker of neoplastic transformation, VEGF. VEGF 
protein levels were found to be elevated in adenocarcinoma samples and low in controls. TTP overexpression in 
Colo320 cells, a human colorectal cell line, correlated with a marked decrease in mRNA stability of VEGF, a 
decrease in cell proliferation, and smaller tumors when these cells were injected into nude mice. These studies 
demonstrate that TTP negatively regulates tumorigenesis, and highlight TTP as a possible target for 
chemoprevention and chemotherapy (Lee et al. 2009). Our results support previous findings that TTP decreases 
during tumor progression; (Brennan et al. 2009) by showing that in an NMSC mouse model, we see a trend 
towards reduction in TTP expression as tumor grade increases; however, these data were not statistically 
significant (Fig. 5). Interestingly, we observed the presence of a TTP doublet in many of our samples. This 
doublet may represent a post-translationally modified species of TTP, as TTP can be extensively phosphorylated 
yielding a size range of 37–50 kD. Either reduction or hyperphosphorylation of the TTP protein has been 
correlated with a transformed phenotype in numerous cancers, including breast, ovarian, and malignant glioma 
(Brennan et al. 2009; Suswam et al. 2008). Thus, more studies investigating the over 20 putative 
phosphorylation sites on TTP need to be conducted to determine both the expression and the physiological 
relevance of these modifications in our system. 
Recently, it has been shown that TTP impairs Myc-induced lymphoma. These studies revealed that Myc 
regulates hundreds of ARE-containing genes and RBPs, including TTP, and TTP suppression was shown to be a 
hallmark of cancers, in which Myc was directly involved in tumorigenesis. The restoration of TTP expression 
compromised Myc-induced tumorigenesis, suggesting that TTP not only acts as a tumor suppressor but also that 
Myc targets various RBPs and ARE-containing transcripts to control neoplastic transformation (Rounbehler et 
al. 2012). These studies are interesting; because, in addition to regulating the RBP TTP, it has been well 
documented that Myc is able to regulate the transcription of Odc (Auvinen et al. 2003; Bello-Fernandez et 
al. 1993; Erdman et al. 1999). However, in the case of Odc, Myc acts as a positive regulator of gene expression. 
These previous studies in addition to our current data suggest a complex network of regulation for ODC and 
further support the notion that ODC is rational target for chemoprevention and/or chemotherapeutics. 
The current studies demonstrate for the first time that ODC is not only post-transcriptionally regulated by the 
stabilizing RBP HuR (Nowotarski and Shantz 2010), but is also a target for the destabilizing RBP TTP. These 
studies reveal a dynamic and complex process of regulation of Odc in both normal cellular physiology and 
pathophysiology. Since ODC mRNA is bound by the stabilizing RBP HuR in a malignant state, one may not expect 
a destabilizing protein, such as TTP to bind to the ODC 3′UTR in Ras12V cells. However, we observed that both 
HuR and TTP bind to the ODC message in Ras12V cells, suggesting that both stabilizing and destabilizing RBPs 
play a role in message regulation in transformed cells. In agreement with this, Lal et al. (2004) showed that HuR 
and the destabilizing RBP AUF1 bound to the 3′UTRs of p21 and Cyclin D1 at different non-overlapping regions, 
suggesting that RBPs can bind to the same mRNA simultaneously. Experiments investigating the competition of 
destabilizing and stabilizing RBPs on the ODC transcript are ongoing, as are experiments determining 
the cis and trans-acting elements on the ODC 3′UTR which influence luciferase expression. 
In conclusion, we describe a novel trans-acting mechanism of ODC regulation. We demonstrate, using a genetic 
approach, that ODC mRNA stability and ODC enzyme activity are increased in cells, in which a functional TTP 
protein has been ablated. These data suggest that the RBP TTP not only binds to the ODC mRNA transcript, but 
also that this interaction between the TTP protein and ODC mRNA transcript is functionally relevant. These 
studies thus add to our knowledge of ODC regulation at the level of mRNA stability. 
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